The effects of airborne pollutants on the immune system have been most
widely studied in the respiratory tract, Entry may occur as a volatil
e gas (ozone, benzene), as liquid droplets (sulfuric acid, nitrogen di
oxide), or as particulate matter (diesel exhaust, aromatic hydrocarbon
s), The subsequent interaction with the immune system may result in lo
cal and systemic responses, and studies have shown examples of disease
occurring from both overactive immune responses and immunosuppression
. For the most part, airborne pollutants (small molecular weight chemi
cals) have to be coupled with other substances (proteins or conjugates
) before they can be recognized by the immune system and exert their e
ffects. Fortunately, this encounter rarely causes immunologically medi
ated human disorders, The following briefly reviews some of the disord
ers that may occur, Immunologically nonspecific inflammation of the lu
ng can occur after inhalation of ozone in anyone given sufficient dose
and time of exposure, Immunologically specific cell-mediated (T lymph
ocyte) reactions appear to predominate in chronic beryllium disease, w
hich results in a granulomatous form of lung disease, Beryllium alone
does not appear to be antigenic but requires chemical linkage with a l
arger molecule, Mercury-induced autoimmune disease (immune system atta
cks self-antigens) affecting kidneys and lungs has been demonstrated i
n animal models (changes similar to those seen in people with Goodpast
ure's syndrome), Immunosuppression can be demonstrated after exposure
to polycyclic aromatic hydrocarbons (2,3,7,8-tetrachlorodibenzo-p-diox
in). Hypersensitivity (or allergic) reactions can occur after exposure
to toluene diisocyanate (occupational asthma). In summary, airborne p
ollutants may cause a wide spectrum of immunologically mediated disord
ers, There is clearly an underlying genetic basis for the susceptibili
ty to immunologic disease resulting from exposure to pollutants, but k
nowledge in this area is rudimentary at present. Studies have been imp
eded by lack of appropriate in vitro models, as well as difficulties i
n identifying the biologically active substance.